 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/836
Drug Delivery 2000: A Key Company and Market Analysis
|
Description: |
Drug Delivery 2000: A Key Company and Market Analysis provides a comprehensive evaluation of enhanced delivery products within the following classes: inhaled, oral, transmucosal, transdermal, topical, injectable, implant, topical and niche technologies and their global sales performance to 2005. For major drug delivery companies, financial performance and strategic alliances are analyzed, together with their current market position and future opportunities. |
|
Contents: |
Introduction to Datamonitor
About Healthcare
TABLE OF CONTENTS
LIST OF TABLES
LIST OF FIGURES
EXECUTIVE SUMMARY
A brief report outline
Four key things you need to know about drug delivery
Demand for drug delivery technologies to protect products from generic competition will expand the drug delivery market to $88.6bn in 2005
Oral, transdermal and inhaled non-invasive formulations of products will lead to higher sales than injected and implanted products
For major pharmaceutical companies, increasing M&A activity between drug delivery companies over the next five years will offer easier access to a broad range of technologies
Small and mid-size pharmaceutical companies will face increasing competition by 2005 from the continuing efforts by one-stop shops to become integrated pharmaceutical companies
THE DRUG DELIVERY MARKET
The drug delivery market
Definition of the drug delivery market
The significance of drug delivery to market success
Product differentiation and improvement of unsuccessful compounds
Protection from generic competition
Return on investment and time to market
Drivers of drug delivery market growth
Overall pharmaceutical market growth
Therapeutic drivers
Drug delivery sector growth
Resistors of drug delivery market growth
Technological innovation is relatively slow
Increasing generic competition in established drug delivery markets
Global market segmentation by drug delivery technology
Global market segmentation by therapy area
Forecasts of future drug delivery market growth
ORAL DRUG DELIVERY
Key oral drug delivery technologies
Controlled release systems
Sustained release
Chronomodulation
The oral drug delivery market
Marketed products
Key pipeline products
Forecast growth of leading products to 2005
Key therapeutic applications
Overview of key companies in the oral drug delivery arena
Cardinal Health
Andrx
Oral drug company delivery strategies
INHALED DRUG DELIVERY
Key technologies
Types of inhaled drug delivery technology
The inhaled drug delivery market
Marketed products
Key pipeline products
Forecast growth of leading products to 2005
Key therapeutic applications
Overview of key companies in the inhaled drug delivery arena
3M
Inhale Therapeutics
Aradigm
Inhaled drug delivery company strategies
TRANSMUCOSAL DRUG DELIVERY
Key technologies
Buccal delivery
Nasal
Rectal
Vaginal
The transmucosal drug delivery market
Marketed products
Key pipeline products
Forecast growth of leading products to 2005
Key therapeutic applications
Overview of key companies in the transmucosal drug delivery arena
Anesta
Transmucosal drug delivery company strategies
INJECTABLE DRUG DELIVERY
Key technologies
Needleless systems
Sustained release injectable systems
Liposomal systems
The injectable drug delivery market
Marketed products
Key pipeline products
Forecast growth of leading products to 2005
Key therapeutic applications
Overview of key companies in the injectable drug delivery arena
Gilead Sciences
Powderject
Injectable drug delivery company strategies
TRANSDERMAL DRUG DELIVERY
Key technologies
The routes of skin penetration
Comparison of oral and transdermal delivery systems
Passive transdermal systems
Electrically assisted transdermal delivery
The transdermal drug delivery market
Marketed products
Key pipeline products
Forecast growth of leading products to 2007
Key therapeutic applications
Overview of key companies in the transdermal drug delivery arena
Watson Laboratories
Noven
Transdermal drug delivery company strategies
NICHE DRUG DELIVERY TECHNOLOGIES
Introduction
The topical drug delivery market
Marketed products
Key pipeline products
Case study of a topical delivery company
The implant drug delivery market
Technical difficulties associated with implant technology
Marketed products
Key pipeline products
Other niche technologies
Marketed products
Key pipeline products
Forecast growth of leading niche products to 2005
Key therapeutic applications of niche technologies
Overview of key companies in the niche drug delivery arena
Guildford Pharmaceuticals
Niche drug delivery company strategies
ONE-STOP DRUG DELIVERY SHOPS
Overview
Definition
Evolution
Advantages and disadvantages of one-stop shops
Alza
Product and pipeline analysis
Financial health
Strategic collaborations
Business strategy
SWOT analysis
Elan
Product and pipeline analysis
Financial health
Strategic collaborations
Business strategy
SWOT analysis
SkyePharma
Product and pipeline analysis
Financial health
Strategic collaborations
Business strategy
SWOT analysis
The future of one-stop drug delivery shops
Comparison of Alza, Elan and SkyePharma
Future strategic development of drug delivery companies
APPENDIX
Research programme methodology
SPRINT databases
Primary Research
|
|
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/836
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 22/08/2008 02:05:58 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Drug Delivery 2000: A Key Company and Market Analysis
|
|
Web Address: |
http://www.researchandmarkets.com/reports/836
|
|
Office Code: |
|
OCHGFNQMQUR
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Hard Copy
|
|
€6,591.00 + EUR€ 50.00 Shipping/Handling *
|
|
Electronic
|
|
€6,955.00
|
|
Electronic
- Site License
|
|
€6,527.00
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World
 |
Page 2 of 2 Printed 22/08/2008 02:05:58
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder Name: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World
|
 |
 |
|
|